FCS Showcases Expertise To Enhance Medically Integrated Oncology Care

Presentations at NCODA International Spring Forum Detail Best Practices in Clinical Advancements, Operational Excellence and Patient Access Optimization

Fort Myers, Fla., April 24, 2025 – Florida Cancer Specialists & Research Institute, LLC (FCS), a leader in pharmacy services within medically integrated oncology care, will share its expertise and best practices in specialty pharmacy operations and dispensing and patient navigation that are contributing to positive patient outcomes at the NCODA 2025 International Spring Forum in Denver.

FCS President & Managing Physician Lucio N. Gordan, MD, said, “We welcome this opportunity to join our clinical and industry colleagues and share top-tier knowledge that is advancing patient-centered cancer treatment throughout the entire care continuum.” Dr. Gordan was appointed to NCODA’s board of directors earlier this year and serves on the Forum’s steering committee. Additionally, FCS Associate Director of Pharmacy Clinical Services Chris Elder, PharmD, BCOP is a chair of the Forum’s planning committee.

Serving as moderators and presenters during collaborative workshops and discussions at the NCODA Spring Forum are:

• Paul Chadwick, FCS Chief Value & Procurement Officer—NCODA’s Non-Profit Partner Update and National Marrow Donor Recipient Story
• Danielle Brown, MBA, BSN, RN, OCN, CN-BN, FCS Vice President of Clinical Services—CPT Navigation: Enhancing Patient Experience and Oncology Outcomes
• Nicole Bentivegna, PharmD, BCOP, FCS Manager of Pharmacy Clinical Services—PQI in Actions: Practical Strategies to Transform Oncology Care

Rx To Go, FCS’ specialty pharmacy that works exclusively within the statewide practice, provides an advanced level of personalized pharmacy services and educational support to ensure that patients use medications appropriately and achieve optimal clinical outcomes. Rx To Go provides timely dispensing and convenient home delivery of oral oncolytic medications, which comprise a growing percentage of the drugs used in cancer treatment today.

“Our teams are leading the way in medically integrated oncology pharmacy and redefining excellence in clinical support services,” said Paul Chadwick. “Through collaborative integration, we are positively enhancing the patient experience and contributing to positive clinical outcomes.”

NCODA (Network for Collaborative Oncology Development & Advancement), a global, medically integrated oncology non-profit organization with a membership of more than 12,000 healthcare practitioners is dedicated to improving patient-centered care in cancer treatment.